Oric Pharmaceuticals, Inc. (ORIC)
13.17
-0.46
(-3.37%)
USD |
NASDAQ |
Oct 23, 16:00
13.16
-0.01
(-0.08%)
After-Hours: 20:00
Oric Pharmaceuticals Price to Book Value : 3.58 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.58 |
| October 22, 2026 | 3.705 |
| October 21, 2026 | 3.765 |
| October 20, 2026 | 3.746 |
| October 19, 2026 | 3.458 |
| October 16, 2026 | 3.357 |
| October 15, 2026 | 3.471 |
| October 14, 2026 | 3.150 |
| October 13, 2026 | 3.074 |
| October 12, 2026 | 3.210 |
| October 09, 2026 | 3.259 |
| October 08, 2026 | 3.270 |
| October 07, 2026 | 3.265 |
| October 06, 2026 | 3.256 |
| October 05, 2026 | 3.395 |
| October 02, 2026 | 3.318 |
| October 01, 2026 | 3.403 |
| September 30, 2026 | 3.662 |
| September 29, 2026 | 3.634 |
| September 28, 2026 | 3.607 |
| September 25, 2026 | 3.577 |
| September 24, 2026 | 3.583 |
| September 23, 2026 | 3.624 |
| September 22, 2026 | 3.670 |
| September 21, 2026 | 3.444 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.477 |
| September 17, 2026 | 3.501 |
| September 16, 2026 | 3.409 |
| September 15, 2026 | 3.360 |
| September 14, 2026 | 3.439 |
| September 11, 2026 | 3.273 |
| September 10, 2026 | 3.281 |
| September 09, 2026 | 3.398 |
| September 08, 2026 | 3.430 |
| September 04, 2026 | 3.496 |
| September 03, 2026 | 3.463 |
| September 02, 2026 | 3.569 |
| September 01, 2026 | 3.504 |
| August 31, 2026 | 3.531 |
| August 28, 2026 | 3.599 |
| August 27, 2026 | 3.735 |
| August 26, 2026 | 3.781 |
| August 25, 2026 | 3.759 |
| August 24, 2026 | 3.659 |
| August 21, 2026 | 3.86 |
| August 20, 2026 | 3.773 |
| August 19, 2026 | 3.982 |
| August 18, 2026 | 3.784 |
| August 17, 2026 | 3.637 |
| August 14, 2026 | 3.770 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 13.17 |
| Earnings Yield | -10.25% |
| Market Cap | 1.365B |